Approaches & Challenges in Choosing the Right Translational Oncology Indication

Logo
Presented by

Zaki Sellam, Gary Brandam, Emmanuel Grillot, Alex Moreau

About this talk

In this innovative panel discussion, industry leaders will gather to share strategies and tactics on how to choose a translational oncology indication in research & development, what data drives that choice, and determine how any potential pitfalls can be avoided. Key discussion topics tackled in this panel discussion: - When and how to choose an indication? - Can it be purely data-driven? - How translational/experimental studies, especially with PDX models could drive such a choice? - What about OMICS data? How can it help? - What are the pitfalls to be avoided? - What about clinical feasibility? How shall it be considered?

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (38)
Subscribers (2423)
Champions Oncology delivers innovative solutions to oncology drug development, accelerating the journey from the research bench to the clinic – decreasing timelines, lowering costs, and ultimately saving patient lives. Learn more about Champions Oncology's capabilities, our service platforms and educational topics affecting our industry on our Webinar Channel.